Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells - PubMed (original) (raw)
. 2007 Feb;292(2):E648-52.
doi: 10.1152/ajpendo.00084.2006. Epub 2006 Sep 19.
Affiliations
- PMID: 16985264
- DOI: 10.1152/ajpendo.00084.2006
Free article
Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells
Ching Fai Kwok et al. Am J Physiol Endocrinol Metab. 2007 Feb.
Free article
Abstract
Recent studies have shown that CD36 plays important roles as a major scavenger receptor for oxidized low-density lipoproteins and as a crucial transporter for long-chain fatty acids. CD36 deficiency might be associated with insulin resistance and abnormal dynamics of long-chain fatty acids. Endothelin-1 (ET-1), which is synthesized and secreted by vascular endothelial cells, is the most potent endogenous vasoconstrictor known and also stimulates the proliferation of vascular smooth muscle cells (VSMCs) and thus is believed to play an important role in the development of various circulatory disorders, including hypertension and atherosclerosis. The aim of the present study was to investigate the regulatory effect of ET-1 on CD36 expression in cultured VSMCs. VSMCs were treated for different times (0-24 h) with a fixed concentration (100 nM) of ET-1 or with different concentrations (0-100 nM) for a fixed time (24 h); then CD36 expression was determined using Western blots. CD36 expression was significantly decreased by ET in a time- and dose-dependent manner. This inhibitory effect was prevented by the ET(A) receptor antagonist BQ-610 (10 microM) but not the ET(B) receptor antagonist BQ-788 (10 microM). To further explore the underlying mechanisms of ET-1 action, we examined the involvement of the tyrosine kinase-mediated and MAPK-mediated pathways. The inhibitory effect of ET-1 on CD36 protein expression was blocked by inhibition of tyrosine kinase activation by use of genistein (100 microM) and by the ERK inhibitor PD-98059 (75 microM) but not by the p38 MAPK inhibitor SB-203580 (20 microM). In conclusion, we have demonstrated that ET-1, acting via the ET(A) receptor, suppresses CD36 protein expression in VSMCs by activation of the tyrosine kinase and ERK pathways.
Similar articles
- Leptin increases endothelin type A receptor levels in vascular smooth muscle cells.
Juan CC, Chuang TY, Lien CC, Lin YJ, Huang SW, Kwok CF, Ho LT. Juan CC, et al. Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E481-7. doi: 10.1152/ajpendo.00103.2007. Epub 2007 Dec 4. Am J Physiol Endocrinol Metab. 2008. PMID: 18056787 - Chronic elevated endothelin-1 concentrations regulate mitogen-activated protein kinases ERK 1 and ERK 2 in vascular smooth muscle cells.
Brehm BR, Klaussner M, Wolf SC. Brehm BR, et al. Clin Sci (Lond). 2002 Aug;103 Suppl 48:137S-140S. doi: 10.1042/CS103S137S. Clin Sci (Lond). 2002. PMID: 12193072 - Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.
de Oliveira Silva C, Delbosc S, Araïs C, Monnier L, Cristol JP, Pares-Herbute N. de Oliveira Silva C, et al. Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):23-30. doi: 10.1016/j.numecd.2006.07.008. Epub 2006 Nov 28. Nutr Metab Cardiovasc Dis. 2008. PMID: 17127041 - Vascular biology of endothelin.
Schiffrin EL, Touyz RM. Schiffrin EL, et al. J Cardiovasc Pharmacol. 1998;32 Suppl 3:S2-13. J Cardiovasc Pharmacol. 1998. PMID: 9883741 Review. - The yin and yang of corpus luteum-derived endothelial cells: balancing life and death.
Meidan R, Levy N, Kisliouk T, Podlovny L, Rusiansky M, Klipper E. Meidan R, et al. Domest Anim Endocrinol. 2005 Aug;29(2):318-28. doi: 10.1016/j.domaniend.2005.04.003. Domest Anim Endocrinol. 2005. PMID: 15927442 Review.
Cited by
- CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia.
Yue H, Febbraio M, Klenotic PA, Kennedy DJ, Wu Y, Chen S, Gohara AF, Li O, Belcher A, Kuang B, McIntyre TM, Silverstein RL, Li W. Yue H, et al. Arterioscler Thromb Vasc Biol. 2019 Feb;39(2):263-275. doi: 10.1161/ATVBAHA.118.312186. Arterioscler Thromb Vasc Biol. 2019. PMID: 30567481 Free PMC article. - CD36 Gene Polymorphisms Are Associated with Intracerebral Hemorrhage Susceptibility in a Han Chinese Population.
Gong QW, Liao MF, Liu L, Xiong XY, Zhang Q, Zhong Q, Zhou K, Yang YR, Meng ZY, Gong CX, Xu R, Yang QW. Gong QW, et al. Biomed Res Int. 2017;2017:5352071. doi: 10.1155/2017/5352071. Epub 2017 Jul 19. Biomed Res Int. 2017. PMID: 28804718 Free PMC article. Clinical Trial. - Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease.
Saavedra MT, Hughes GJ, Sanders LA, Carr M, Rodman DM, Coldren CD, Geraci MW, Sagel SD, Accurso FJ, West J, Nick JA. Saavedra MT, et al. Am J Respir Crit Care Med. 2008 Nov 1;178(9):929-38. doi: 10.1164/rccm.200803-387OC. Epub 2008 Aug 21. Am J Respir Crit Care Med. 2008. PMID: 18723435 Free PMC article. - Complicated atheromatous plaque as integral atherogenesis.
Agius LM. Agius LM. J Clin Pathol. 2007 Jun;60(6):589-92. doi: 10.1136/jcp.2006.044107. Epub 2006 Nov 1. J Clin Pathol. 2007. PMID: 17079352 Free PMC article. Review. - CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs.
Li W, Febbraio M, Reddy SP, Yu DY, Yamamoto M, Silverstein RL. Li W, et al. J Clin Invest. 2010 Nov;120(11):3996-4006. doi: 10.1172/JCI42823. Epub 2010 Oct 11. J Clin Invest. 2010. PMID: 20978343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous